Glycated albumin:an effective marker for assessing glycemic control in diabetic inpatients

LI Qing,WU Songhua,TU Yinfang,TANG Junling,PAN Jiemin,LI Ming,ZHOU Jian,JIA Weiping,XIANG Kunsan
2009-01-01
Abstract:Objective To examine the serum glycated albumin(GA) level in diabetic inpatients and to assess its reliability as a clinical marker of short-term blood glucose level and blood glucose control of diabetic inpatients.Methods A total of 445 type 2 diabetic patients,who were treated in our in-patient department from May 2006 to November 2007,were enrolled in the present study.The fasting plasma glucose(FPG),post-prandial plasma glucose(2hPG),GA,and HbA_1 c,were observed.The above parameters were measured again on day 12 of hospitalization in 101 patients who were treated for more than two weeks.GA-Ⅰtechnique was used to determine GA.Results①The GA value was positively correlated with HbA_1 c,FPG,2hPG and MBG,with the coefficients being 0.818,0.573,0.409 and 0.313,respectively(P<0.01).②The GA level in 101 patients was ([23.24±4.51]%) 12 days after admission,significantly lower than that on the first day of admission([30.10±6.75]%,P<0.01).③The GA level decreased by 6.86%in the 101 patients on day 12 of admission compared with that of the pre-treatment level(P<0.01),with a mean cutting down of 21.19%;and the HbA_1 c value decreased by 0.74%(P<0.01),with a mean cutting down of 6.38%.The decrease degree of GA was more severe that that of HbA_1c(P<0.01).Conclusion GA can accurately,promptly reflect the change of mean glycemic level.Compared with HbA_1c,GA is a more suitable clinical monitoring marker for evaluating the glucose control in diabetic inpatients.
What problem does this paper attempt to address?